Biomatter will be published later in 2011. Submissions will be received from March 2011.
Cover image (Volume 1, Issue 0): Histological section showing inflammatory response of implanted chitosan. Image courtesy of my colleagues Judite N. Barbosa and Mário A. Barbosa, from INEB (2009).
Pedro L. Granja
Biomatter appears as a forum to discuss and disclose the relevant advancements in the exciting and fast growing field of science and application of biomaterials. It is widely anticipated that current and future developments will soon result in products with potential to dramatically change the way in which we live, probably even with yet unimaginable future implications in healthcare.
Biomatter is an international and transdisciplinary journal for publication of peer-reviewed original research exploring the clinical and laboratory investigations in the field of science and application of biomaterials, including their physico-chemical and biological properties, as well as clinical performance, and especially those emphasizing the correlation between biomaterials structure and biological performance. The journal intends to cover all applications of biomaterials, including implantable medical devices, drug delivery systems, nanomedicine, tissue engineering and regenerative medicine.
Biomatter is intended to help researchers, academics, clinicians, industry professionals and policy makers, working in related fields of science, engineering and health sciences, to disseminate information associated to biomaterials and its related fields.
Scope of Biomatter
Recent developments in medicine have resulted in a considerable and unprecedented increase in life span. The invention of artificial implants made from biomaterials, in the 1960s, created a whole new scientific field and resulted in revolutionary technologies that strongly contributed to this increase in life expectancy. Since then, many exciting advancements shaped the modern biomaterials science, which itself originated several new fields, with biology playing a major role and where the separation between engineering and health sciences can hardly be distinguishable. Current and future research efforts in this field are believed to result in new therapeutic approaches to prevent and treat debilitating and life-threatening diseases.
Biomatter covers all types of synthetic and natural biomaterials (metals, ceramics, polymers and composites) used for biomedical applications.
Contents and Topics
Biomatter publishes original articles, review articles, short communications and letters to the Editor.
Biomatter covers, but is not limited to, the following topics in the context of biomaterials science:
- Advanced materials
- Animal Models
- Antimicrobial strategies
- Artificial cells, tissues and organs
- Biocompatibility studies
- Biodegradable materials
- Biological response
- Biomaterials synthesis and characterization
- Biomimetic strategies
- Biosensors and screening devices
- Blood substitutes
- Cell engineering
- Cell, tissue and organ transplantation
- Clinical Trials
- Drug delivery systems
- Experimental methodologies
- Fluid dynamics, modeling and simulation
- Gene therapy
- In vitro and in vivo approaches
- Interactions between materials and cells and proteins
- Medical devices
- Nanomedicine and nanotechnology
- Regenerative medicine
- Regulatory and ethical issues
- Repair, replacement and Regeneration
- Smart multifunctional intelligent systems
- Stem cell biology
- Structure-property-function relationship
- Surfaces, interfaces and functionalization
- Tissue engineering
Note to Potential Authors
Biomatter accepts only manuscripts that have not been previously published nor currently submitted for publication elsewhere.
All manuscripts are peer-reviewed. The guidelines for authors, sample copies and other relevant information for submitting manuscripts are available on the Guidelines for Authors webpage.
Page and color charges are waived for the first six issues and the final version of accepted manuscripts will be posted on the website promptly. Any content posted on the web site from now until January 2012 will be free for registered users during our first year of publication (see the Subscribewebpage). Authors will receive a free print version of the issue containing their paper. For additional information on how to submit your manuscript please visit our guidelines.
Submit your manuscript to Biomatter
Submissions and peer review will be rapid and handled online. The average time from submission to acceptance (or rejection) for the current Landes Bioscience journals is one month. Once accepted, a paper is published online within three weeks.
We will begin accepting submissions in March 2011.
Biomatter will utilize an online submission and tracking system designed to provide efficient service to authors. Through the online system, author files are automatically converted to PDFs, submissions are acknowledged by email, and authors can track their manuscript through the stages of the peer review process.